1)Vermeulen A:Andropause. Maturitas 34:5-15, 2000
2)Morley JE:Andropause, testosterone therapy, and quality of life in aging male. Cleve Clin J Med 67:880-882, 2000
3)Morales A and Lunenfeld B:ISSAM:Investigation, treatment, and monitoring of late-onset hypogonadism in males:official recommendations of ISSAM. Aging Male 5:74-86, 2002
4)Nieschlag E, Swerdloff R, Behre HM, et al:Investigation, treatment, and monitoring of late-onset hypogonadism in males:ISA, ISSAM, and EAU recommendations. Int J Androl 28:125-127, 2005
5)日本泌尿器科学会/日本Men's Health医学会「LOH症候群診療ガイドライン」検討ワーキング委員会編:LOH症候群 加齢男性性腺機能低下症候群 診療の手引き.じほう,東京,2007
6)岩本晃明,高 栄哲,並木幹夫,他:日本人成人男子の総テストステロン,遊離テストステロンの基準値の設定.日泌尿会誌95:751-760,2004
7)Vikan T, Schirmer H, Njølstad I, et al:Endogenous sex hormones and the prospective association with cardiovascular disease and mortality in men:the Tromsø Study. Eur J Endocrinol 161:435-442, 2009
8)Tivesten A, Vandenput L, Labrie F, et al:Low serum testosterone and estradiol predict mortality in elderly men. J Clin Endocrinol Metab 94:2482-2488, 2009
9)Laughlin GA, Barrett-Connor E, Bergstrom J, et al:Low serum testosterone and mortality in older men. J Clin Endocrinol Metab 93:68-75, 2008
10)Lehtonen A, Huupponen R, Tuomilehto J, et al:Serum testosterone but not leptin predicts mortality in elderly men. Age Ageing 37:461-464, 2008
11)Khaw KT, Dowsett M, Folkerd E, et al:Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men:European Prospective Investigation Into Cancer in Norfolk(EPIC-Norfolk)Prospective Population Study. Circulation 116:2694-2701, 2007
12)Shores MM, Matsumoto AM, Sloan KL, et al:Low serum testosterone and mortality in male veterans. Arch Intern Med 166:1660-1665, 2006
13)Hyde Z, Norman PE, Flicker L, et al:Low free testosterone predicts mortality from cardiovascular disease but not other causes:the Health in Men Study. J Clin Endocrinol Metab 97:179-189, 2012